|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CASE REPORT |
1 Department of Paediatrics, Royal Victoria Infirmary, Newcastle upon Tyne Hospitals NHS Trust, Newcastle upon Tyne, NE1 4LP, UK2 The Institute of Human Genetics, International Centre for Life, Newcastle University, Central Parkway, Newcastle upon Tyne, NE1 3BZ, UK3 Department of Endocrinology and Royal Victoria Infirmary, Newcastle upon Tyne Hospitals NHS Trust, Newcastle University, Newcastle upon Tyne, NE1 4LP, UK
(Correspondence should be addressed to T D Cheetham at Department of Paediatrics, Institute of Human Genetics, International Centre for Life, Royal Victoria Infirmary, Newcastle upon Tyne Hospitals NHS Trust, Newcastle University; Email: tim.cheetham{at}nuth.nhs.uk)
Abstract
Background: Activating mutations of the vasopressin receptor gene on the X chromosome cause the nephrogenic syndrome of inappropriate antidiuresis (NSIAD). We describe a male child who presented with persistent hyponatraemia and whose mother was also found to be hyponatraemic. She had learnt to avoid excess fluid consumption because of associated malaise. Both individuals had a subnormal ability to excrete a water load with mother also demonstrating a heightened sense of thirst at low serum osmolalities.
Results: Mother and child were found to have the previously characterised activating mutation (p.Arg137Cys) of the arginine vasopressin receptor type 2 gene (AVPR2), but had measurable levels of AVP when hyponatraemic.
Conclusions: We conclude that female carriers of activating mutations of the vasopressin receptor are susceptible to hyponatraemia and therefore need to be provided with advice regarding fluid intake. An altered thirst perception may increase susceptibility to hyponatraemia. We confirm that the presence of measurable amounts of AVP in patients with hyponatraemia does not exclude the diagnosis of NSIAD.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |